Pulmonary Disease in a Psychiatric Inpatient Population

Pulmonary Disease in a Psychiatric Inpatient Population, a Screening Study

Purpose: Patients with mental health disorders have a reduced life expectancy, compared to the general population. The shorter life expectancy is caused by natural and unnatural death. In general, patients with a mental disorder tend to have a more unhealthy lifestyle, than the general population, characterized by e.g. lack of exercise and smoking.

Hypothesis

Chronic obstructive pulmonary disease (COPD) is underdiagnosed in psychiatric inpatients There is a higher prevalence of COPD in psychiatric inpatients compared to the general population Screening of patients with one respiratory symptom and a smoking history, has the same sensitivity regarding to diagnosis of COPD, as screening all patients with a smoking history

Method:

80 psychiatric inpatients will undergo spirometry with reversibility test and COPD Assessment Test (CATest). Furthermore, patient history regarding respiratory symptoms and smoking will be taken into account.

Study Overview

• Status: Completed
• Conditions: Chronic Obstructive Airway Disease
• Intervention / Treatment: Procedure: Spirometry with reversibility test

• Study Type: Interventional
• Enrollment (Actual): 46
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Denmark
  • Vordingborg, Denmark, 4760
    • Psyciatrien Syd, Region Zealand

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 75 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Inpatients in Psykiatrien Syd, Region Zealand, ward S1,S2,S3,S4,S5,S6
• Admission time over 48 hours

Exclusion Criteria:

• Patients who is not able to perform spirometry due to their psychiatric condition

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Spirometry with reversibility test	Procedure: Spirometry with reversibility test; Spirometry with reversibility test and CATest questionaire. following will be measured FEV1 L/s FVC L/s FEV1/FVC ration; Other Names: MicroLoop handheld transportable spirometer

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Tiffeneau index	- FEV1/FVC ratio	at enrollment

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
forced vital capacity	FVC L/s	at enrollment
Forced expiratory volume in 1 second	FEV1 L	at enrollment

Collaborators and Investigators

• Sponsor: Psykiatrien Syd
• Collaborators: Naestved Hospital
• Investigators: Principal Investigator: Nicolai Renstrom, Psykiatrien Syd

Study record dates

Study Major Dates

• Study Start: March 1, 2013
• Primary Completion (Actual): June 1, 2013
• Study Completion (Actual): July 1, 2013

Study Registration Dates

• First Submitted: March 26, 2013
• First Submitted That Met QC Criteria: April 2, 2013
• First Posted (Estimate): April 4, 2013

Study Record Updates

• Last Update Posted (Actual): May 24, 2018
• Last Update Submitted That Met QC Criteria: May 22, 2018
• Last Verified: May 1, 2018

More Information

Terms related to this study

• Keywords: COPD; Smoking; Psychiatric inpatient
• Additional Relevant MeSH Terms: Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive
• Other Study ID Numbers: SJ-322

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No